Certified by Founder Lodge
Cirrus Therapeutics
United States - Cambridge, Massachusetts
START UP
1 Disclosed Funding Rounds $11,000,000
0 Participating Investments
-
Founded date
2022
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Cirrus Therapeutics is an ocular immunology-focused company co-founded by Dr. Kai Chan, former Chief Scientific Officer of Ally Therapeutics and Blavatnik Fellow at Harvard Business School, a
| Date | Round | Raised | Participating Investors |
|---|---|---|---|
| October, 07 ,2025 | Seed | $11,000,000 |
Polaris Partners
ClavystBio
Carmot Therapeutics, Inc.
Ozette Technologies
NAPIGEN, INC.
TrueBinding
Loopworm
XCENA | $135,000,000 | (Jun 2, 2026)
Human Archive (YC W26) | $8,200,000 | (Jun 2, 2026)
SpeedLabs | $6,500,000 | (Jun 2, 2026)
Invertix | $1,977,831 | (Jun 2, 2026)
Gray Swan | $40,000,000 | (Jun 2, 2026)
